At a glance
- Originator Nonindustrial source
- Class Analgesics; Anti-inflammatories; Antirheumatics
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 02 Sep 1998 No-Development-Reported for Inflammation in Saudi Arabia (Unknown route)
- 02 Sep 1998 No-Development-Reported for Pain in Saudi Arabia (Unknown route)